Dolutegravir and Voriconazole drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Dolutegravir (dolutegravir) and Voriconazole (voriconazole). Common drug interactions include escherichia urinary tract infection among females and diarrhoea among males.

The phase IV clinical study analyzes what interactions people have when they take Dolutegravir and Voriconazole. It is created by eHealthMe based on reports of 35 people who take the same drugs from the FDA, and is updated regularly.

What is Dolutegravir?

Dolutegravir has active ingredients of dolutegravir. eHealthMe is studying from 7,071 Dolutegravir users. Check the latest studies of Dolutegravir.

What is Voriconazole?

Voriconazole has active ingredients of voriconazole. It is often used in aspergillosis. eHealthMe is studying from 21,706 Voriconazole users. Check the latest studies of Voriconazole.



On Aug, 05, 2026

35 people who take Dolutegravir and Voriconazole together, and have interactions are studied.

Dolutegravir and Voriconazole drug interactions.

What are the common drug interactions of Dolutegravir and Voriconazole, by gender? *:

female:

  1. Escherichia urinary tract infection (urinary tract infection by escherichia coli)
  2. Viral oesophagitis (inflammation of the oesophagus caused by viral infection)
  3. Oesophagitis (inflammation of oesophagus)

male:

  1. Diarrhoea
  2. Respiratory failure (inadequate gas exchange by the respiratory system)
  3. Disease recurrence
  4. Dysphagia (a condition in which swallowing is difficult or painful)
  5. Pyrexia (fever)
  6. Cd4 lymphocytes decreased
  7. Central nervous system lesion (an abnormality in tissue of brain or spinal cord)
  8. Cerebral venous thrombosis (clot in brains venous blood system)
  9. Emotional distress
  10. Encephalitis (inflammation of the brain)

What are the common drug interactions of Dolutegravir and Voriconazole, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Escherichia urinary tract infection (urinary tract infection by escherichia coli)
  2. Viral oesophagitis (inflammation of the oesophagus caused by viral infection)
  3. Oesophagitis (inflammation of oesophagus)
  4. Pseudoporphyria (skin changes consistent with one of the porphyrias, but laboratory tests do not detect significant abnormalities)

40-49:

  1. Diarrhoea
  2. Respiratory failure (inadequate gas exchange by the respiratory system)
  3. Dyspnoea (difficult or laboured respiration)
  4. General physical health deterioration (weak health status)
  5. Oedema (fluid collection in tissue)
  6. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  7. Respiratory gas exchange disorder (gas exchange disease of respiratory system)
  8. Drug ineffective
  9. Dysphagia (a condition in which swallowing is difficult or painful)
  10. Blood hiv rna increased

50-59:

  1. Disease recurrence
  2. Hydrocephalus (water on the brain)
  3. Hypokalaemia (low potassium)
  4. Lethargy (tiredness)
  5. Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
  6. Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
  7. Pyrexia (fever)
  8. Seizure (abnormal excessive or synchronous neuronal activity in the brain)

60+:

  1. Encephalitis (inflammation of the brain)
  2. Meningitis cryptococcal (bacterial inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges)
  3. Hydrocephalus (water on the brain)
  4. Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
  5. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  6. Antiviral drug level below therapeutic
  7. Blood hiv rna increased
  8. Brain herniation (brain herniation is a potentially deadly side effect of very high intracranial pressure that occurs when a part of the brain is squeezed across structures within the skull)
  9. Brain oedema (excess accumulation of fluid in the intracellular or extracellular spaces of the brain)
  10. Brain stem haemorrhage (bleeding into structures of brain stem)

What are the existing conditions these people have? *

  1. Hiv Infection: 15 people, 42.86%
  2. Meningitis Cryptococcal (bacterial inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges): 10 people, 28.57%
  3. Affective Disorder (mental disorder): 5 people, 14.29%
  4. Bacterial Infection: 4 people, 11.43%
  5. Acquired Immunodeficiency Syndrome (disease of the human immune system caused by the human immunodeficiency virus (hiv)): 3 people, 8.57%
  6. Bone Marrow Conditioning Regimen: 3 people, 8.57%
  7. Pneumonia Cryptococcal (pneumonia caused by cryptococcal infection): 3 people, 8.57%
  8. Pneumonia Bacterial (pneumonia associated with bacterial infection): 3 people, 8.57%
  9. Pneumonia: 3 people, 8.57%
  10. Acute Hiv Infection: 2 people, 5.71%

* Approximation only. Some reports may have incomplete information.

Do you take Dolutegravir and Voriconazole?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Dolutegravir and Voriconazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Dolutegravir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Voriconazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Dolutegravir and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Voriconazole and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on dolutegravir and voriconazole (the active ingredients of Dolutegravir and Voriconazole, respectively), and Dolutegravir and Voriconazole (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: